[Suave]

Originally Posted by freedogger

Has anyone here looked seriously at Oncolytics Biotech? I wouldn't call their product, reolysin a cure, but it does have a lot of potential for certain kinds of cancers. UofC research lead to this discovery. A Calgary company that I have been watching for longer than a decade. 2012 should see FDA approval for head and kneck cancer.
http://www.oncolyticsbiotech.com/tech.html

I am in the same boat as you, been an investor for over a decade. Following this stock has really helped me learn about cancer research and the road to regulatory approval. It is a very long and often frustrating process but a necessary one. As results in a lab don't often preform the same way in real life. That is way you often read a article like in the OP. but then never hear about the company or "the cure" for years. Here are some similar articles about Oncolytics and I am sure you could find hundreds about other research.

Oncolytics going viral
Cancer treatment built on virus goes to trial
Dina O'Meara, Calgary Herald
Published: Saturday, September 05, 2009
For a drug to reach the market it generally has to go through extensive research and testing on animals, then four phases of controlled clinical trials on humans. The third phase is considered the most important stage in any new drug's development.

Results of controlled, multi-centre trials during this period provide a clear assessment of how effective a drug is, making or breaking years, often decades, of research.

Ten years have passed since Oncolytics launched seed financing to develop Reolysin. Since then, the company has enrolled approximately 330 patients in clinical studies, gone public, raising $12 million in cash as of June, and recently partnered with the Cancer Therapy and Research Center at the University of Texas Health Sciences Center in San Antonio.
http://www2.canada.com/calgaryherald...7-c594a6e69a62

Cancer victims push for access to drug
David Heyman, Calgary Herald, April 17, 2002

News that a Calgary Company may have a cure for cancer has led to a gusher of calls from hundreds of ill people desperate to have the experimental treatment.

Brad Thompson, president and CEO of Oncolytics, said Tuesday he gets five to 10 calls a day from people suffering from cancer begging for its drug Reolysin.

Reolysin has shown tremendous promise in clinical trials, but it will take a few more years before Health Canada has enough data to approve its distribution to the general public.

Thompson said it is very difficult to tell people they can’t have a drug that hold as-yet-unproven life-saving possibilities, but government rules forbid it for the time being.

"They’re thinking the more we focus on getting the product developed, the sooner it’s out on the market, so everybody can take advantage of it.” Thompson said Tuesday. "It’s tough on individual people, but from a population perspective I think they’re probably correct.”


http://www.siliconinvestor.com/readm...msgid=17343481